Lv3
238 积分 2024-04-30 加入
IND-Enabling Studies for a TCR-T targeting a pancreatic cancer G12V KRAS mutation
7小时前
求助中
IND-Enabling Studies for a TCR-T targeting a pancreatic cancer G12V KRAS mutation
7小时前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
19天前
已完结
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies
25天前
已完结
RE: Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies
25天前
已关闭
The present and future of bispecific antibodies for cancer therapy
29天前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
29天前
已完结
Presetting CAR-T cells during ex vivo bio-manufacturing
29天前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
